Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1991 | 1 |
1992 | 1 |
2008 | 1 |
2010 | 1 |
2016 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Urinary neutrophil chemotactic factors in interstitial cystitis patients and a rabbit model of bladder inflammation.
J Urol. 1992 May;147(5):1382-7. doi: 10.1016/s0022-5347(17)37578-x.
J Urol. 1992.
PMID: 1569692
Bacillus Calmette-Guérin with or without interferon α-2b and megadose versus recommended daily allowance vitamins during induction and maintenance intravesical treatment of nonmuscle invasive bladder cancer.
Nepple KG, Lightfoot AJ, Rosevear HM, O'Donnell MA, Lamm DL; Bladder Cancer Genitourinary Oncology Study Group.
Nepple KG, et al.
J Urol. 2010 Nov;184(5):1915-9. doi: 10.1016/j.juro.2010.06.147. Epub 2010 Sep 17.
J Urol. 2010.
PMID: 20846688
Clinical Trial.
Item in Clipboard
A 1-year, open label, randomized phase II dose finding study of degarelix for the treatment of prostate cancer in North America.
Gittelman M, Pommerville PJ, Persson BE, Jensen JK, Olesen TK; Degarelix Study Group.
Gittelman M, et al.
J Urol. 2008 Nov;180(5):1986-92. doi: 10.1016/j.juro.2008.07.033. Epub 2008 Sep 17.
J Urol. 2008.
PMID: 18801505
Clinical Trial.
Item in Clipboard
Leukocyte chemotactic factors in interstitial cystitis: a possible biological marker of the disease.
Walzak MP Jr, Elgebaly SA, Allam ME, Oselinsky D.
Walzak MP Jr, et al. Among authors: oselinsky d.
Semin Urol. 1991 May;9(2):131-5.
Semin Urol. 1991.
PMID: 1853010
No abstract available.
Item in Clipboard
Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study.
Nitti VW, Ginsberg D, Sievert KD, Sussman D, Radomski S, Sand P, De Ridder D, Jenkins B, Magyar A, Chapple C; 191622-096 Investigators.
Nitti VW, et al.
J Urol. 2016 Sep;196(3):791-800. doi: 10.1016/j.juro.2016.03.146. Epub 2016 Mar 30.
J Urol. 2016.
PMID: 27038769
Clinical Trial.
Item in Clipboard
Cite
Cite